Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis


Leblebisatan G., Bay A., Karakus S. C. , Kekilli M., HAZNEDAROĞLU İ. C.

BLOOD COAGULATION & FIBRINOLYSIS, vol.23, no.6, pp.494-497, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 6
  • Publication Date: 2012
  • Doi Number: 10.1097/mbc.0b013e32834fa837
  • Title of Journal : BLOOD COAGULATION & FIBRINOLYSIS
  • Page Numbers: pp.494-497

Abstract

Ankaferd blood stopper (ABS) is a hemostatic agent used topically for controlling bleedings of skin or mucosal surfaces in Turkey. It is currently topically used in bleedings of body injuries, traumas, and minor or major surgical interventions. Here we have evaluated 12 pediatric patients with hemorrhagic diathesis on whom Ankaferd was used for oral bleedings. Topical Ankaferd was administered for hemorrhages of oral cavity during 15 bleeding attacks. ABS administrations successfully stopped the bleedings, except for one patient with oral hemorrhage who did not respond to ABS application. Ankaferd is effective for oral bleedings of children with bleeding diathesis especially when other measures have failed. Blood Coagul Fibrinolysis 23:494-497 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.